Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03390491 · ClinicalTrials.gov registry record · NA
OnTrack>An Online Role-Playing Game for Young People With First Episode Psychosis
A NA study, sponsored by Center for Social Innovation, Massachusetts.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT03390491: Completed NA study, sponsored by Center for Social Innovation, Massachusetts.
NCT03390491 is a NA study that has completed, run by Center for Social Innovation, Massachusetts. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03390491, a NA study, has completed, sponsored by Center for Social Innovation, Massachusetts.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
The research team will develop and test a prototype version of OnTrack\>An Online Role-Playing Game (OnTrack\>The Game or OTG), an online role-playing game designed for youth and young adults experiencing First Episode Psychosis (FEP). Phase I showed positive changes in quantitative measures of hope and recovery, as well as an enthusiastic response to the prototype as evidenced by qualitative interviews. In Phase II, the research team will refine, expand and finalize OTG and evaluate the effectiveness of OTG.
Primary Outcome
Improved treatment engagement in participants from OTG condition compared to the control condition, RV (measured by a. Signh O'Brien Level of Engagement Scale, b. Engagement with CSC program determined by record review)
Interventions
- BEHAVIORAL OnTrack>TheGame (OTG)
- BEHAVIORAL Recovery Videos (RV)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2021-07-31 |
| Phase | NA |
What the finished NCT03390491 record still lists
NCT03390491 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which OnTrack>TheGame (OTG) is the first listed.
NCT03390491 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03390491 about?
NCT03390491 is a clinical study titled "OnTrack>An Online Role-Playing Game for Young People With First Episode Psychosis". The research team will develop and test a prototype version of OnTrack\>An Online Role-Playing Game (OnTrack\>The Game or OTG), an online role-playing game designed for youth and young adults experiencing First Episode Psychosis (FEP). Phase I showed positive changes in quantitative measures of hope...
What is the current status of trial NCT03390491?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2018-11-01. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT03390491?
The interventions under investigation include: OnTrack>TheGame (OTG) (BEHAVIORAL), Recovery Videos (RV) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03390491?
This trial is sponsored by Center for Social Innovation, Massachusetts, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03390491's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI